Table 2.

Organisms and AMR in patients with HCAI

Type of HCAI	Value, n (%)
bloodstream infection	3 (11.5)
pneumonia	15 (57.7)
UTI	8 (30)
Gram-positive organisms	10 (38.5)
E. faecalis	5 (19.2)
E. faecium	2 (7.7)
S. aureus	2 (7.7)
S. epidermidis	1 (3.8)
Gram-negative organisms	16 (61.5)
P. aeruginosa	5 (19.2)
E. coli	4 (15.4)
K. oxytoca	3 (11.5)
Haemophilus influenzae	2 (7.7)
Citrobacter freundii	1 (3.8)
K. pneumoniae	1 (3.8)
Type of HCAI	Organism	Resistance
bloodstream infection	E. faecium	nil
bloodstream infection	S. epidermidis	nil
bloodstream infection	E. faecalis	nil
pneumonia	C. freundii	nil
pneumonia	E. faecium	nil
pneumonia	H. influenzae	nil
pneumonia	H. influenzae	nil
pneumonia	K. oxytoca	nil
pneumonia	K. oxytoca	ceftazidime
pneumonia	K. oxytoca	piperacillin/ tazobactam
pneumonia	K. pneumoniae (ESBL)	nil
pneumonia	P. aeruginosa	ciprofloxacin
pneumonia	P. aeruginosa	ertapenem
pneumonia	P. aeruginosa	imipenem
pneumonia	P. aeruginosa	nil
pneumonia	P. aeruginosa	nil
pneumonia	S. aureus	nil
pneumonia	S. aureus	nil
UTI	E. faecalis	nil
UTI	E. faecalis	nil
UTI	E. faecalis	nil
UTI	E. faecalis	nil
UTI	E. coli	nil
UTI	E. coli	nil
UTI	E. coli	gentamicin
UTI	E. coli	gentamicin

UTI, urinary tract infection.